New blood test could help reduce lung cancer deaths

New blood test could help reduce lung cancer deaths

PanARMENIAN.Net - A ground-breaking blood test could cut the number of people who die from lung cancer each year, Sky News reports.

Lung cancer is the third most common cancer but it has a very high mortality rate. Less than 9% of patients survive more than five year after diagnosis - often because it is spotted too late.

A trial of 12,209 high-risk patients in Scotland found that those who took the blood test were diagnosed at an earlier stage than those who received standard care.

Oncimmune Holdings, the global company that designed the test, said it works by detecting autoantibodies made by the body's immune system as a natural defence against cancer cells.

In a statement, it said: "Lung cancer was chosen as the first target of the technology because it is the world's leading cause of cancer-related death and is often detected at an advanced stage with approximately 85% of patients in the UK undiagnosed until the disease has spread to other parts of the body."

 Top stories
A spokesperson, said a doctor gave her a vaccination on Friday, then tested positive for the virus shortly after.
Czechs and foreign nationals with permanent or long-term residence will not be allowed to leave the country.
Ravindra Gupta said the new test results were "even more remarkable" and likely demonstrated the patient was cured.
The company got its first break with a contract to build code-making machines for U.S. troops during World War II.
Partner news